Pls refer the attachment
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Smallcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre Limited's Board meeting on May 07, 2026 covered multiple items. The Board noted approved audited standalone and consolidated financial results for Q4 and FY ended March 2026. A final dividend of ₹2 per share (200% on ₹1 face value) was recommended, subject to shareholder approval at the AGM. Dr. D Nageshwar Reddy will not seek re-appointment for a second term as Independent Director effective May 25, 2026 due to other commitments. The company granted 1,79,500 ESOPs at ₹784 per option (20% discount to 3-month average price) under the VDCL ESOP Plan 2018, vesting over 1-4 years. The Board also approved acquisition of MRI, EEG and NCV services business from Medinova Millennium MRI Services LLP, a wholly-owned subsidiary, for ~₹4.20 crore in cash, expected to complete in 3 months. MRI LLP has turnover of approximately ₹2.36 crore in FY 2025-26.
The acquisition from a wholly-owned subsidiary is a related-party transaction, consolidating diagnostic services under the parent. The ESOP grant aligns employee and shareholder interests. No adverse financial signals were flagged in this filing, though specific revenue or PAT figures were not detailed in the announcement text.